DCM patients with variants in the SCN5A gene exhibit a phenotype associated with significant arrhythmias and poor response to HF therapy, while treatment with sodium channel blocking drugs reduces the amount of ectopy and normalizes LVEF [40]. The gene discussed is SCN5A; the disease is familial dilated cardiomyopathy.